Skip to content
SQM

Sociedad Quimica y Minera de Chile SA

Sociedad Quimica y Minera de Chile SA Q3 FY2024 earnings call

November 20, 2024 · fiscal period ended 2024-09

EPS · actual vs est

$0.46 / $0.66Miss -30.0%

Revenue · actual vs est

$1.08B / $1.06BBeat +1.2%
Ask about this call

Summary

Generated 2024-11-20

Management highlights

  • Specialty Plant Nutrition: Solid dynamics with market size recovery, volumes up >20% YOY, revenues up >12%, stable prices midterm. - Iodine: Subtle price increase since年初, strong demand and limited supply, projects to increase efficiency, seawater pipeline on schedule. - Lithium: First revenue from Mt. Holland, first spodumene concentrate bidding event, refinery commissioning to start mid-2025, sales volumes up 18% YOY, prices down 24% QoQ due to oversupply but demand growing strongly.
View in transcript ↓

Segment performance

Specialty Plant Nutrition: Volumes grew more than 20% year-on-year, increasing revenues by more than 12% despite lower prices during the period. Iodine: Subtle but continued price increase since the beginning of the year, strong demand growth and limited supply could lead to slight price increases in coming quarters. Lithium: First revenue from Mt. Holland, sales volumes of more than 51,000 metric tons of lithium products with 18% year-on-year growth, prices down 24% QoQ due to temporary oversupply but demand continues to grow strongly.

View in transcript ↓

Guidance

  • Lithium: Sales guidance 190,000-195,000 tons for 2024, no curtailment planned for 2025, expected lithium demand to grow strongly with EV market driving demand. - Iodine: Demand expected to grow 7% in 2024, moderated growth next year, new supply in 2025-2026 but unlikely to meet demand.
View in transcript ↓

Risks

  • SEC investigation: Request for info and subpoena regarding FCPA and anticorruption laws, internal review ongoing. - Competitor actions: Australian competitors cutting capacity, potential impact on profitability.
View in transcript ↓

Q&A highlights

Q: Joel Jackson asked about whether SQM needs to cut share or volume to support the market and guidance.

A: Felipe Smith said SQM is expecting to reach sales volumes close to 195,000 tons in 2024 and no curtailment planned for 2025.

Q: Joel Jackson asked about Australia operations, Mt. Holland sales, guidance, and conversion plant profitability.

A: Mark Fones said Mt. Holland 2024 production range is 110,000-130,000 tons of spodumene concentrate, tolling in China, and confident in refinery project.

Q: Ben Isaacson asked about lithium outlook for 2025 and iodine market.

A: Pablo Hernandez said lithium demand strong, expected to surpass 1.1 million tons in 2024, and Juan Pablo Bellolio said iodine market size ~38-39k tons, growth 7% in 2024, new supply in 2025-2026.

Q: Corinne Blanchard asked about Codelco agreement and SEC investigation.

A: Ricardo Ramos said Codelco agreement moving as expected, Gerardo Illanes said SEC investigation is nonpublic fact finding, internal review ongoing.

Q: Gabriel Simões asked about volumes and costs.

A: Carlos Diaz and Mark Fones provided details on production volumes and costs, Mark Fones on Mt. Holland production.

Q: César Pérez-Novoa asked about lithium sales volumes and iodine inventory.

A: Mark Fones said lithium sales volumes in third quarter, Pablo Altimiras said iodine demand growth and inventory usage.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$0.46$0.66-30.0%
Revenue$1.08B$1.06B+1.2%

Transcript

November 20, 2024

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.